Regencell Bioscience Holdings Limited
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 33.7% | 33.7% | -395.9% |
| FY2022 | -43.6% | -43.6% | -41.3% |
| FY2023 | -48.8% | -48.8% | -46.5% |
| FY2024 | -52.3% | -52.3% | -51.0% |
| FY2025 | -73.7% | -73.7% | -62.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 33.7% | 33.7% | -395.9% |
| FY2022 | -43.6% | -43.6% | -41.3% |
| FY2023 | -48.8% | -48.8% | -46.5% |
| FY2024 | -52.3% | -52.3% | -51.0% |
| FY2025 | -73.7% | -73.7% | -62.3% |